Youle M - Search Results

1

Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Youle M. Youle M. CNS Drugs. 2007;21 Suppl 1:25-30; discussion 45-6. doi: 10.2165/00023210-200721001-00004. CNS Drugs. 2007. PMID: 17696590 Review.

2

Didanosine once daily: an overview.

Youle M. Youle M. Antivir Ther. 1998;3 Suppl 4:35-7. Antivir Ther. 1998. PMID: 10723507 Review.

3

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.

Mocroft A, Devereux H, Kinloch-de-Loes S, Wilson D, Madge S, Youle M, Tyrer M, Loveday C, Phillips AN, Johnson MA. Mocroft A, et al. Among authors: youle m. AIDS. 2000 Jul 28;14(11):1545-52. doi: 10.1097/00002030-200007280-00010. AIDS. 2000. PMID: 10983641 Clinical Trial.

4

Assessing the cost-effectiveness of HAART for adults with HIV in England.

Miners AH, Sabin CA, Trueman P, Youle M, Mocroft A, Johnson M, Beck EJ. Miners AH, et al. Among authors: youle m. HIV Med. 2001 Jan;2(1):52-8. doi: 10.1046/j.1468-1293.2001.00048.x. HIV Med. 2001. PMID: 11737376 Free article.

5

Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?

Moore AL, Youle M, Lipman M, Cozzi-Lepri A, Lampe F, Madge S, Nesaratnam S, Tyrer M, Cuthbertson Z, Ransom D, Loveday C, Johnson MA, Phillips AN; Royal Free Centre for HIV Medicine. Moore AL, et al. Among authors: youle m. AIDS. 2002 Mar 8;16(4):615-8. doi: 10.1097/00002030-200203080-00013. AIDS. 2002. PMID: 11873005

6

Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma.

Hart AM, Wiberg M, Youle M, Terenghi G. Hart AM, et al. Among authors: youle m. Exp Brain Res. 2002 Jul;145(2):182-9. doi: 10.1007/s00221-002-1100-2. Epub 2002 May 4. Exp Brain Res. 2002. PMID: 12110958

7

Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression.

Phillips AN, Staszewski S, Lampe F, Youle MS, Klauke S, Bickel M, Sabin CA, Doerr HW, Johnson MA, Loveday C, Miller V; Royal Free Centre for HIV Medicine; Goethe Universität Clinic Cohort. Phillips AN, et al. Among authors: youle ms. J Infect Dis. 2002 Oct 15;186(8):1086-91. doi: 10.1086/343801. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355358 Free article.

8

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, Prinz B, Youle M, Johnson MA, Phillips AN. Smith CJ, et al. Among authors: youle m. AIDS. 2003 May 2;17(7):963-9. doi: 10.1097/00002030-200305020-00004. AIDS. 2003. PMID: 12700445

9

Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection.

Phillips AN, Youle MS, Lampe F, Johnson M, Sabin CA, Lepri AC, Loveday C. Phillips AN, et al. Among authors: youle ms. AIDS. 2003 May 2;17(7):1009-16. doi: 10.1097/00002030-200305020-00009. AIDS. 2003. PMID: 12700450

10

Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy.

Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, Youle M. Hart AM, et al. Among authors: youle m. AIDS. 2004 Jul 23;18(11):1549-60. doi: 10.1097/01.aids.0000131354.14408.fb. AIDS. 2004. PMID: 15238773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters